Insights

Innovative AI Platform Semalytix's Pharos platform leverages cutting-edge AI and large language models to analyze vast amounts of real-world data, providing pharmaceutical companies with actionable patient insights. This positions the company as a valuable partner for pharma firms seeking to enhance patient-centric strategies through advanced analytics.

Growing Financial Backing Recent successful funding rounds totaling over 12 million USD signal strong investor confidence and financial stability, enabling Semalytix to expand its service offerings and target larger pharmaceutical clients increasingly looking for AI-driven solutions.

Market Expansion Potential With more than 40 projects completed for the pharmaceutical industry and a revenue range of 1 to 10 million USD, Semalytix demonstrates proven market traction and growth potential, making it attractive for enterprise pharma companies aiming for competitive advantages.

Specialized Industry Focus Semalytix’s focus on serving pharmaceutical companies with tailored AI solutions creates opportunities to develop strategic partnerships and upsell services within the healthcare sector, especially as pharma firms seek more patient insights for product development and marketing.

Competitive Positioning Compared to larger competitors, Semalytix’s niche specialization in real-world data analysis and patient-centric insights provides a distinctive value proposition that can be emphasized to persuade pharma companies to adopt their innovative AI platform.

Semalytix Tech Stack

Semalytix uses 8 technology products and services including HubSpot Analytics, HubSpot Cookie Policy Banner, MongoDB, and more. Explore Semalytix's tech stack below.

  • HubSpot Analytics
    Analytics
  • HubSpot Cookie Policy Banner
    Cookie Compliance
  • MongoDB
    Database
  • Swiper
    Javascript Libraries
  • Priority Hints
    Performance
  • Personio
    Recruitment Marketing
  • ZURB Foundation
    UI Frameworks
  • HTTP/3
    Web & Portal Technology

Semalytix's Email Address Formats

Semalytix uses at least 2 format(s):
Semalytix Email FormatsExamplePercentage
First.Last@semalytix.deJohn.Doe@semalytix.de
96%
Last@semalytix.deDoe@semalytix.de
4%
First.Last@semalytix.comJohn.Doe@semalytix.com
94%
Last@semalytix.comDoe@semalytix.com
6%

Frequently Asked Questions

Where is Semalytix's headquarters located?

Minus sign iconPlus sign icon
Semalytix's main headquarters is located at Meller Straße 2, Bielefeld, Deutschland (DEU) 33613, DE. The company has employees across 2 continents, including EuropeAsia.

What is Semalytix's official website and social media links?

Minus sign iconPlus sign icon
Semalytix's official website is semalytix.com and has social profiles on LinkedIn.

What is Semalytix's NAICS code?

Minus sign iconPlus sign icon
Semalytix's NAICS code is 5112 - Software Publishers.

How many employees does Semalytix have currently?

Minus sign iconPlus sign icon
As of October 2025, Semalytix has approximately 51 employees across 2 continents, including EuropeAsia. Key team members include Chief Product Officer, Managing Director, Co-Founder: J. J.Vp Global Marketing: S. R.Vice President Of Business Development: K. W.. Explore Semalytix's employee directory with LeadIQ.

What industry does Semalytix belong to?

Minus sign iconPlus sign icon
Semalytix operates in the Software Development industry.

What technology does Semalytix use?

Minus sign iconPlus sign icon
Semalytix's tech stack includes HubSpot AnalyticsHubSpot Cookie Policy BannerMongoDBSwiperPriority HintsPersonioZURB FoundationHTTP/3.

What is Semalytix's email format?

Minus sign iconPlus sign icon
Semalytix's email format typically follows the pattern of First.Last@semalytix.de. Find more Semalytix email formats with LeadIQ.

When was Semalytix founded?

Minus sign iconPlus sign icon
Semalytix was founded in 2015.

Semalytix

Software DevelopmentGermany51-200 Employees

Welcome to Semalytix!

Semalytix, the trailblazer in AI-driven innovations, empowers pharmaceutical companies to embrace a patient-centric approach like never before. With their revolutionary Pharos platform, fuelled by state-of-the-art AI and LLM technology, Semalytix undertakes the colossal task of consuming and analysing millions of forum posts, social media discussions, and CRM system records in the blink of an eye.

Pharos becomes the conduit for capturing and harnessing the pulse of real-world perceptions and experiences shared by both healthcare practitioners and patients in the here and now. Through its captivating living reports, Pharos bestows invaluable insights upon pharmaceutical giants, guiding them to laser-focus on their customers' genuine needs. It unlocks the profound understanding of what truly holds the potential to enhance their well-being, transforming lives in ways previously unimagined. 

Founded in 2015, Semalytix has grown to a team size of 75 employees and has executed more than 40 projects with the pharmaceutical industry with a total volume of EUR 3.8M between 2015 – 2019.

Section iconCompany Overview

Headquarters
Meller Straße 2, Bielefeld, Deutschland (DEU) 33613, DE
NAICS Code
5112 - Software Publishers
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    Semalytix's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Semalytix's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.